Newsroom

  • Category

  • By Date

  • Press Release

    17 January 24

    CuraTeQ Biologics’ Trastuzumab Biosimilar receives recommendation for marketing authorization in India

    Read more
  • Press Release

    20 November 23

    CuraTeQ Biologics eyes ‘WuXi’ moment to kickstart Indian bio-CDMO sector

    Read more
  • Press Release

    10 July 23

    CuraTeQ Biologics to market Ustekinumab biosimilar to treat Crohn’s disease, arthritis

    Read more